Related Experiment Video
Updated: Jun 11, 2025
05:42
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
31.2K
Unveiling Niaprazine's Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent
Hanna Trebesova1, Martina Monaco1, Sara Baldassari2
1Pharmacology and Toxicology Unit, Department of Pharmacy, University of Genova, 16148 Genoa, Italy.
Biomedicines
|September 28, 2024
Summary
Niaprazine (NIA) shows potential as an anti-anxiety and anti-stress agent in mice. This piperazine derivative reduced anxiety behaviors without causing significant adverse effects or impacting exploration.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Global research focuses on understanding stress and anxiety impacts on health.
- Niaprazine (NIA), a piperazine derivative, is being investigated for therapeutic potential, particularly for anxiety.
- Limited research exists on NIA's behavioral effects.
Purpose of the Study:
- To investigate Niaprazine's efficacy as an anti-anxiety and anti-stress agent.
- To evaluate the behavioral effects of NIA administration in a mouse model.
- To assess potential adverse effects and synaptic toxicity of NIA.
Main Methods:
- Mice received either vehicle or Niaprazine (NIA) in drinking water for 14 days.
- Behavioral analyses included the Marble Burying Test and Elevated Plus Maze test.
- Stability and preliminary synaptic toxicity studies were conducted.
Main Results:
- NIA-treated mice exhibited reduced anxiety behaviors, spending more time in open arms and burying fewer marbles.
- A dose-dependent response was confirmed, with no significant impact on exploratory activity.
- Preliminary synaptic toxicity analysis indicated no direct damage to cortical nerve endings.
Conclusions:
- Niaprazine demonstrates potential as a safe and tolerable agent for managing anxiety-related behaviors.
- NIA may offer a novel therapeutic option for anxiety and stress management.
- Further research is warranted to explore NIA's full therapeutic potential and mechanisms of action.
Related Concept Videos
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
563
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
563
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
151
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
151
01:26Anxiolytic Drugs: Overview
238
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
238
01:23Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
203
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
203
01:23Sedatives and Hypnotics: Overview
287
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
287